Cyclosporine
Cyclosporine is a drug that suppresses immune organization function. Doctors prescribe it for the treatment of autoimmune conditions, including rheumatoid arthritis and psoriasis, and to prevent organ rejection after a transplant. Cyclosporine is an alternative treatment for autoimmune conditions such as Rheumatoid Arthritis (RA) and psoriasis. Doctors tend near suggest it after first-line treatments have not been effective. While regularly effective, cyclosporine can cause a range of side effects. Persons can work with their doctor to control whether or not cyclosporine is the right treatment option for them. Cyclosporine is a prescription medication that doctors use to treat autoimmune conditions such as RA and psoriasis. It comes in many forms, including oral tablets, an oral solution, then eye drops. Doctors also use Cyclosporine to help prevent the body from rejecting an organ after a solid organ transplant.
Related Conference of Cyclosporine
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Cyclosporine Conference Speakers
Recommended Sessions
- Cyclosporine
- Drug Delivery in Transplantation
- Heart transplant
- Immunosuppressant
- Kaposi Sarcoma in case of solid organ transplantation
- Kidney transplant
- Lung transplant
- Medicine - Surgery
- Organ Donation
- Organ Rejection
- Organ Transplantation
- Organ Transplantation Market to Ascent Exponentially
- Skin & Tissue Grafting
- Stem Cell Transplantation
- Transplant Survival and Transplant Living
- Transplantation Special legal and Ethical problems
- Trends in Organ Transplantation
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)

